Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tran-epidermal Water Loss (TEWL) as a Predictive Marker for Diabetic Foot Ulcer (DFU) Recurrence

NCT04558775 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT04558775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04558775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tran-epidermal Water Loss (TEWL) as a Predictive Marker for Diabetic Foot Ulcer (DFU) Recurrence
Lead sponsor
University of Michigan
Phase
Observational
Overall status
Completed
Start date
June 17, 2020
Completion date
December 30, 2022
Enrollment
418 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetic, diabetic foot, diabetic foot ulcer, diabetic wound